title: Management of male osteoporosis: lessons for clinical practice.
authors.forename: Bernard
authors.initials: B
authors.lastname: Cortet
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Biver
authors.forename: Séverine
authors.initials: S
authors.lastname: Borg
authors.forename: Florence
authors.initials: F
authors.lastname: Chopin
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Hoppé
authors.forename: Michel
authors.initials: M
authors.lastname: Laroche
authors.forename: Gauthier
authors.initials: G
authors.lastname: Morel
authors.forename: Gérald
authors.initials: G
authors.lastname: Razjbaum
authors.forename: Christian
authors.initials: C
authors.lastname: Roux
authors.forename: Thierry
authors.initials: T
authors.lastname: Thomas
authors.forename: Erick
authors.initials: E
authors.lastname: Legrand
mesh_terms: D000367:Age Factors; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001862:Bone Resorption / Q000188:drug therapy; D004035:Diet Therapy; D005598:Fractures, Spontaneous / Q000517:prevention & control*; D012739:Gonadal Steroid Hormones / Q000172:deficiency / Q000502:physiology / Q000627:therapeutic use; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D058866:Osteoporotic Fractures / Q000517:prevention & control*
chemical_list: D050071:Bone Density Conservation Agents; D012739:Gonadal Steroid Hormones